Ensure you have adequate lighting so you can clearly see the markings on your syringe or the dial on your medication pen
Topical is the more evidence-supported route, especially for skin endpoints
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, not a pure GLP-1 agonist
Selectively stimulates pituitary somatotrophs to release GH No significant cortisol or prolactin elevation in research models Compatible with CJC-1295 for synergistic, sustained GH environment Studied for lean mass support, fat loss, improved sleep quality, and recovery 3
Fortunately, the government allows compounding pharmacies to prepare the syringes and you can start treatment by scheduling with your WholeHealth Chicago practitioner
By activating both of these pathways, compounded GLP-1 therapy offers a dual approach to appetite regulation and weight management